BioNexus Gene Lab Corp. (BGLC) Earnings Dates & History
NASDAQ·Healthcare·Medical - Diagnostics & Research
$2.40
+13.27%
Mkt Cap $4.02M
EPS — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 14, 2026 | — | $483.76K | — | — | -$0.52 | — |
| Q4 2025 Nov 14, 2025 | — | $2.54M | — | — | -$0.39 | — |
| Q3 2025 Aug 18, 2025 | — | $2.26M | — | — | -$0.34 | — |
| Q2 2025 May 15, 2025 | — | $2.14M | — | — | -$0.03 | — |
| Q2 2025 Apr 15, 2025 | — | $2.52M | — | — | -$0.19 | — |
| Q4 2024 Nov 15, 2024 | — | $2.63M | — | — | -$0.20 | — |
| Q3 2024 Aug 14, 2024 | — | $1.97M | — | — | $0.10 | — |
| Q2 2024 May 31, 2024 | — | $2.57M | — | — | -$0.18 | — |
| Q2 2024 May 15, 2024 | — | $2.38M | — | — | -$0.18 | — |
| Q1 2024 Mar 29, 2024 | — | $2.27M | — | — | $0.17 | — |
| Q4 2023 Nov 20, 2023 | — | $2.55M | — | — | -$0.20 | — |
| Q4 2022 Nov 14, 2022 | — | $2.58M | — | — | -$0.05 | — |
| Q3 2022 Aug 15, 2022 | — | $2.49M | — | — | -$0.10 | — |
| Q2 2022 May 16, 2022 | — | $3.03M | — | — | $0.01 | — |
| Q2 2022 Apr 6, 2022 | — | $3.25M | — | — | $0.06 | — |
| Q4 2021 Nov 15, 2021 | — | $3.58M | — | — | $0.21 | — |
| Q3 2021 Aug 12, 2021 | — | $3.09M | — | — | $0.02 | — |
| Q2 2021 May 18, 2021 | — | $3.45M | — | — | $0.24 | — |
| Q1 2021 Mar 30, 2021 | — | $11.36M | — | — | $1.47 | — |
| Q4 2020 Nov 3, 2020 | — | $23.47K | — | — | $0.27 | — |
| Q3 2020 Aug 11, 2020 | — | $6.54K | — | — | -$0.08 | — |
| Q2 2020 May 8, 2020 | — | $3.07M | — | — | $1.25 | — |
| Q1 2020 Mar 31, 2020 | — | $53.05K | — | — | -$0.11 | — |
| Q4 2019 Nov 14, 2019 | — | $24.17K | — | — | -$0.03 | — |
| Q3 2019 Aug 9, 2019 | — | $21.64K | — | — | -$0.11 | — |
| Q2 2019 May 15, 2019 | — | $28.09K | — | — | -$0.10 | — |
| Q4 2018 Dec 31, 2018 | — | $9.41K | — | — | -$0.12 | — |
| Q3 2018 Sep 30, 2018 | — | $91.63K | — | — | -$0.16 | — |
| Q2 2018 Jun 30, 2018 | — | $111.30K | — | — | -$0.07 | — |
| Q1 2018 Mar 31, 2018 | — | — | — | — | $0.64 | — |
| Q4 2017 Dec 31, 2017 | — | $64.52K | — | — | -$0.15 | — |